Cargando…
Salidroside inhibits endothelial-mesenchymal transition via the KLF4/eNOS signaling pathway
Homocysteine (Hcy) was discovered to be an independent risk factor for the development of atherosclerosis (AS). Moreover, endothelial-mesenchymal transition (EndMT) was found to be one of main mechanisms contributing to the pathogenesis of AS. Salidroside (SAL) has diverse pharmacological activities...
Autores principales: | Huang, Yongpan, Han, Xiaodong, Tang, Jiayu, Long, Xian, Wang, Xiaoye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365603/ https://www.ncbi.nlm.nih.gov/pubmed/34368873 http://dx.doi.org/10.3892/mmr.2021.12324 |
Ejemplares similares
-
EOFAZ inhibits endothelial-to-mesenchymal transition through downregulation of KLF4
por: Zhang, Yanyan, et al.
Publicado: (2020) -
Neurogranin regulates eNOS function and endothelial activation
por: Cheriyan, Vino T., et al.
Publicado: (2020) -
PKC-Dependent Phosphorylation of eNOS at T495 Regulates eNOS Coupling and Endothelial Barrier Function in Response to G(+) -Toxins
por: Chen, Feng, et al.
Publicado: (2014) -
Endothelial NO Production Is Mandatory for Epigallocatechin-3-Gallate–induced Vasodilation: Results From eNOS Knockout (eNOS(−/−)) Mice
por: Lorenz, Mario, et al.
Publicado: (2015) -
Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease
por: Hebbel, Robert P., et al.
Publicado: (2021)